Mark Schoenberg Net Worth & Insider Trades
Mark Schoenberg - Chief Medical Officer, Urogen Pharma Ltd
What is Mark Schoenberg's Net Worth?
The current estimated net worth of Urogen Pharma Ltd's Chief Medical Officer, Mark Schoenberg, is estimated to be about $306.47K . Mark Schoenberg owns about 148,560 units of Urogen Pharma Ltd common stock. In the last 4 years at Urogen Pharma Ltd, Mark Schoenberg has sold an estimated value of $245.01K worth.
What is Mark Schoenberg's Past Insider Trading?
Mark Schoenberg's largest purchase order was 1,960 units , worth over $55.21K on November 21, 2019. Mark Schoenberg's largest sale order was 1,991 units , worth over $74.26K on March 7, 2019. In total, Mark Schoenberg has made about 33 transactions over 4 years of their time at Urogen Pharma Ltd. Mark Schoenberg usually trades in January, with the busiest year in 2020 and 2021. The most recent transaction was a sale order of 1,900 units , worth over $19.23K on February 2, 2023.
Mark Schoenberg
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Mark Schoenberg's Salary in 2020?
As Chief Medical Officer of Urogen Pharma Ltd, Mark Schoenberg has a total base salary of $185,026 . Mark Schoenberg received compensation valued at about $948,458 in 2020 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of a bonus of $0 , stock awards of $176,460 , option awards of $292,054 , other earnings, plans or compensations of $293150 , and other compensation of $1,767 .
What is Mark Schoenberg's' Mailing Address?
- Mailing address is C/o Urogen Pharma Ltd. 9 Ha Ta Asiya Street Ra Anana L3 4365007 Israel
Urogen Pharma Ltd Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Elizabeth Barrett | 2020 | $636,987 | $0 | $441,150 | $876,164 | $468,650 | $43,716 | $2,466,667 |
| Elizabeth Barrett | 2019 | $694,697 | $300,000 | $15,082,782 | $8,979,216 | $840,000 | $4,128 | $25,900,823 |
| Molly Henderson | 2020 | $94,269 | $100,000 | $294,900 | $787,994 | $69,875 | $15,192 | $1,362,230 |
| Peter P. Pfreundschuh | 2020 | $324,329 | $0 | $176,460 | $292,055 | $218,800 | $152,313 | $1,163,956 |
| Peter P. Pfreundschuh | 2019 | $435,625 | $0 | $212,500 | $436,108 | $261,375 | $1,183 | $1,346,791 |
| Peter P. Pfreundschuh | 2018 | $156,424 | $0 | $527,875 | $1,704,505 | $96,800 | $197 | $2,485,800 |
| Stephen L. Mullennix | 2020 | $139,311 | $0 | $88,230 | $292,055 | $140,200 | $246,581 | $906,376 |
| Stephen L. Mullennix | 2019 | $435,625 | $0 | $212,500 | $436,108 | $261,375 | $904 | $1,346,512 |
| Stephen L. Mullennix | 2018 | $359,754 | $70,000 | $1,102,893 | $2,552,946 | $223,400 | $575 | $4,309,568 |
| Mark Schoenberg | 2020 | $185,026 | $0 | $176,460 | $292,054 | $293150 | $1,767 | $948,458 |
| Mark Schoenberg | 2019 | $205,000 | $0 | $106,250 | $218,054 | $270,000 | $1,604 | $800,908 |
| Mark Schoenberg | 2018 | $200,000 | $0 | $0 | $0 | $100,000 | $0 | $300,000 |
| Jason Smith | 2020 | $126,930 | $100,000 | $491,500 | $785,242 | $92,083 | $19,518 | $1,615,274 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1668243/000156459021021330/urgn-def14a_20210607.htm
What are Urogen Pharma Ltd's Past Insider Trades?
Urogen Pharma Ltd's most recent insider trade came on February 2, 2023 by Jason D. Smith Attorney-In-Fact who sold 1,636 units worth $16.56K . In the last 6 years, insiders at Urogen Pharma Ltd have sold an estimated value of $9.79M and bought an estimated value of $3.32M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Mark Schoenberg, Chief Medical Officer, Elizabeth Barrett, Chief Executive Officer, and Peter Pfreundschuh, Chief Financial Officer .
UroGen Pharma Ltd. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||